152786-08-8

Basic information

• Product Name: 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI)
• Synonyms: 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI)
• CAS NO: 152786-08-8
• Molecular Formula: C7H12O4
• Molecular Weight: 160.17
• Product Categories: CARBOXYLICACID
• Mol File: 152786-08-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI)(152786-08-8)
• EPA Substance Registry System: 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI)(152786-08-8)

Safety Data

• Hazardous Substances Data: 152786-08-8(Hazardous Substances Data)

Usage

Explanation

A carboxylic acid derivative is a compound that has undergone a chemical modification from a carboxylic acid, which contains a -COOH functional group. 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI) has a carboxylic acid group attached to a dioxolane ring.
3. Dioxolane Ring

Explanation

A dioxolane ring is a four-membered ring containing two oxygen atoms and two carbon atoms. In 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI), the carboxylic acid group is attached to the dioxolane ring.
4. Three Methyl Groups

Explanation

Methyl groups are alkyl groups derived from methane (CH4), consisting of one carbon atom bonded to three hydrogen atoms. 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI) has three methyl groups attached to the dioxolane ring.

Explanation

Stereoisomers are compounds with the same molecular formula but different spatial arrangements of atoms. 1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI) is a mixture of stereoisomers, with the trans isomer being the most stable form.
6. Trans Isomer Stability

Explanation

The trans isomer of 1,3-Dioxolane-4-carboxylic acid, 2,2,5-trimethyl is more stable than the cis isomer due to the reduced steric hindrance and lower energy conformation.
7. Organic Synthesis

Explanation

1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,trans-(9CI) is commonly used in organic synthesis, which involves the formation of new chemical compounds through the manipulation of existing organic compounds.
8. Building Block in Manufacturing

Explanation

It serves as a building block in the manufacturing of pharmaceuticals, agrochemicals, and other specialty chemicals, contributing to the formation of more complex molecules.
9. Stability and Selectivity

Explanation

The trans isomer of 1,3-Dioxolane-4-carboxylic acid, 2,2,5-trimethyl is known for its stability and selectivity in certain chemical reactions, making it a valuable tool for researchers and manufacturers in various industries.

Stereoisomers

Mixture of cis and trans isomers

Upstream product

• 38410-80-9 methyl (4S)-trans-2,2,5-trimethyl-1,3-dioxolane-4-carboxylate 
• 67-64-1 acetone 
• 82010-51-3 (4S)-cis-2,2,5-trimethyl-1,3-dioxolane-4-carboxaldehyde 
• 23334-72-7 (2S,3S)-2,3-dihydroxybutanoic acid 
• 77-76-9 2,2-dimethoxy-propane 
• 151005-02-6 2,3-acetonide-methyl butyrate 
• 78086-72-3 (2R,3S)-4-desoxy-2,3-O-isopropylidene-L-threonate de methyle 
• 114951-10-9 N-<(4R,5S)-2,2,5-trimethyl-1,3-dioxolane-4-carbonyl>bornane-10,2-sultam 
• 78016-90-7 (4R,5R)-methyl 5-iodomethyl-2,2-dimethyl-1,3-dioxolane-4-carboxylate 
• 67812-34-4 (4R,5S)-5-Methanesulfonyloxymethyl-2,2-dimethyl-[1,3]dioxolane-4-carboxylic acid methyl ester 
• 1336854-09-1 biphenyl-4-ylmethyl (4R,5S)-2,2,5-trimethyl-1,3-dioxolane-4-carboxylate 
• 105227-99-4 (4S,5S)-4-(1,3-dithian-2-yl)-2,2,5-trimethyl-1,3-dioxolane 
• 67844-13-7 methyl (4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate 
• 37031-29-1 (-)-dimethy-2,3-O-isopropylidene-L-tartrate 

Downstream Products

• 107914-67-0 N-<(4R,5S)-2,2,5-Trimethyl-1,3-dioxolan-4-ylcarbonyl>-DL-2-phenylglycin-3-methyl-2-butenylester 
• 155322-89-7 (4S,5R)-2,2,5-trimethyl[1,3]dioxolane-4-carbonyl chloride 

Relevant articles and documents

METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE

Disclosed is a method for synthesizing sapropterin dihydrochloride. The present invention reduces a synthesis route of the sapropterin dihydrochloride, and resolves a racemate intermediate or an intermediate having a low antimer isomerism value by using a chiral resolving reagent, thereby obtaining an intermediate having a high antimer isomerism value. Raw materials are cheap and readily available, and the cost is significantly reduced, hence providing an effective scheme for mass industrial production of the sapropterin dihydrochloride.

METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE

Disclosed is a method for synthesizing sapropterin dihydrochloride. The present disclosure reduces a synthesis route of the sapropterin dihydrochloride, and resolves a racemate intermediate or an intermediate having a low antimer isomerism value by using a chiral resolving reagent, thereby obtaining an intermediate having a high antimer isomerism value. Raw materials are cheap and readily available, and the cost is significantly reduced, hence providing an effective scheme for mass industrial production of the sapropterin dihydrochloride.

METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE

Disclosed is a method for synthesizing sapropterin dihydrochloride. The present disclosure reduces a synthesis route of the sapropterin dihydrochloride, introduces a chiral center in an asymmetric synthesis manner, in which a tetrahydrofuran solution containing a samarium catalyst is adopted as a catalyst, and obtains a target compound having a high antimer isomerism value by means of selective catalysis. The yield is improved, raw materials are cheap and readily available, and the cost is significantly reduced, hence providing an effective scheme for mass industrial production of the sapropterin dihydrochloride.

METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE

Disclosed is a method for synthesizing sapropterin dihydrochloride. The present invention reduces a synthesis route of the sapropterin dihydrochloride, introduces a chiral center in an asymmetric synthesis manner, in which a tetrahydrofuran solution containing a samarium catalyst is adopted as a catalyst, and obtains a target compound having a high antimer isomerism value by means of selective catalysis. The yield is improved, raw materials are cheap and readily available, and the cost is significantly reduced, hence providing an effective scheme for mass industrial production of the sapropterin dihydrochloride.

Total synthesis of (-)-Jiadifenin

As easy as ABCD: (-)-Jiadifenin was synthesized in eighteen reaction steps from 1-[(E)-(4′-bromo-2′-butenyl)oxy]-4-methoxybenzene. Key features of this synthesis include: 1) Ireland-Claisen rearrangement to produce the two contiguous quaternary centers at

Scalable synthesis of enantiomerically pure syn -2,3-dihydroxybutyrate by sharpless asymmetric dihydroxylation of p -phenylbenzyl crotonate

An efficient four-step synthetic route to the useful chiral building block (2R,3S)-dihydroxybutyric acid acetonide in >95% ee is detailed. The sequence is readily scaled, requires no chromatography, and allows for efficient recycling of p-phenylbenzyl alcohol, an expedient for enantio- and diastereoenrichment by recrystallization.

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF

It is intended to provide a compound represented by the general formula (I): (I) (wherein all the symbols are as defined in the description) which has a p38 MAP kinase inhibitory activity, a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. The compound of the invention is useful for preventing or treating a disease in which the abnormal production of a cytokine such as an inflammatory cytokine or a chemokine or overreaction to them is considered to be involved in the cause and aggravation of pathological conditions, in other words, an inflammatory disease, a respiratory disease, a cardiovascular disease, a central nervous system disease or the like, which is a cytokine-mediated disease.

A Selective Baeyer-Villiger Oxidation: A Total Synthesis of (-)-Acetomycin

A short, stereoselective synthesis of (-)-acetomycin (2) from L-threonine is reported.The final step in the synthesis is a selective Baeyer-Villiger oxidation that discriminates between two methyl ketones.

ENZYMATIC ENANTIOSELECTIVE HYDROLYSIS OF 2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXYLIC ESTERS

2,2-dimethyl-1,3-dioxolane-4-carboxylic acid derived chiral building blocks were prepared from substituted α,β-unsaturated acids with high enantiomeric purities by enzymatic hydrolysis of their n.butyl esters.

Synthesis of (-)-Biopterin Using (S)-Ethyl Lactate as a Starting Material

(-)-Biopterin was synthesized from (1S,2S)-1-(1,3-dithian-2-yl)propane-1,2-diol 5 (=C), which was derived from commercially available (S)-ethyl lactate.Diol 5 (=C) was converted to 15 through a six-step sequence.Ketone 15 was submitted to condensation with 3,5,6-triaminopyrimidinol (TAP, 2), and followed by oxidation to afford isopropylidenebiopterin (16).Finally, 16 was deprotected to give (-)-biopterin (1).